Navigation Links
Osteoporosis Drugs: right time to take-off

Millions of Indians are at risk of developing osteoporosis. While women are more likely to develop the disease, men are equal sufferers from it. It is estimated that at the age of 50, a woman has a 40 per cent chance of developing an osteoporotic fracture during her remaining lifetime. Drugs, which are used to treat osteoporosis, can be grouped into two classes. The first category comprises agents, which limit the rate of bone loss and are referred to as ‘‘anti-resorption drugs’’. The second group of drugs promotes bone formation and is referred to as ‘‘bone forming drugs’’.

// No single class of drugs is perceived to manage osteoporosis on a standalone basis. Hormone Replacement Therapy (HRT) and bisphosphonates are the most prescribed drugs. Calcium, vitamins and alfacalcidol preparations are also prescribed for prevention. The anti-osteoporosis market includes multinationals like Glaxo-Smithkline, Novartis, Infar and Wyeth Lederle. The Indian companies who have notched up a substantial market share are Cipla, Dr Reddy’s Laboratories and Elder Pharmaceuticals.

The Indian osteoporosis medications market presents great opportunity. Indian pharmaceutical companies need to increase awareness levels about the disease and it’s implications on both the physician as well as patient level. New compounds that rebuild bone mass and are associated with minimal side effects represent another area of opportunity. Currently, Selective Oestrogen Receptors Modulators (SERMs) such as Raloxifene and new generation bisphosphonates such as Risedronate have not been introduced in the Indian market. These drugs have a better efficacy and fewer side effects than the current therapies.

The osteoporosis medications market is viewed as a typical lifestyle related disease with high brand loyalty. Current lifestyle disease markets like cardiovascular and diabetes therapies are gradually getting saturated. The time is right for Indian pharmaceutical companies to focus on the osteoporosis medications market. br>

'"/>




Related medicine news :

1. New treatment for Osteoporosis
2. Osteoporosis in men
3. Fluoride Found Effective in Osteoporosis
4. Mutation connected to Osteoporosis
5. Osteoporosis associated with Childhood Cancer
6. A treatment for Osteoporosis
7. Osteoporosis could be caused by irregular periods
8. Back exercises reduces Osteoporosis
9. Osteoporosis and kidney stones gene marker identified
10. The Answer To Prevent Osteoporosis
11. Blood Tests Can Help Detect Osteoporosis Early In Life
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading ... to advocate for action towards gender equality at their inaugural Summit in New York ... globe, and reached a social audience of over 3 million. To watch the Mobilize ...
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
(Date:10/12/2017)... ... 12, 2017 , ... The American College of Medical Informatics (ACMI) will present ... the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium ... Collen, a pioneer in the field of medical informatics, this prestigious award is presented ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader ... a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were ... 11, 2017. , The annual award competition recognizes editorial and design excellence across a ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... Korea , Oct. 4, 2017  South Korean-based ... next-generation CPR training aide "cprCUBE" on Kickstarter. The device ... compression during cardiac arrests with better efficiency compared to ... also offers real-time feedback on efficacy of the compression ... crowdfunding campaign has a goal to raise $5,000. ...
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and Company ... results for the third quarter of 2017 on Tuesday, ... call on that day with the investment community and ... The conference call will begin at 9 a.m. ... access a live webcast of the conference call through ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
Breaking Medicine Technology: